NCT05224622已完成不适用
Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study.
Scentech Medical Technologies Ltd2 个研究点 分布在 1 个国家目标入组 192 人开始时间: 2022年1月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 192
- 试验地点
- 2
- 主要终点
- Presence of Volatile Organic Compounds indicating carriers of COVID-19.
研究概览
简要总结
Detection of the 2019 novel Coronavirus (SARS-CoV-2) using breath analysis - Validation study.
详细描述
A diagnostic prospective single-site study, with no anticipated risks or constraints.
Primary objective- To validate the value of a set of breath VOC biomarkers that enable the investigator to distinguish between COVID-19 carriers and COVID-19 non-carriers in comparison to the gold-standard testing methodology.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 18 to 75 years at the time of consent
- •Capable of understanding written and/or spoken language
- •Able to provide informed consent
- •Was not treated with Anti-viral drugs
排除标准
- •Age under 18 years old
- •Under guardianship or deprived of liberty
- •Pregnant or lactating woman
结局指标
主要结局
Presence of Volatile Organic Compounds indicating carriers of COVID-19.
时间窗: Through the study completion, up to 3 months.
Obtain early verification accuracy of measures for a set of VOCs biomarkers indicating carriers of Corona virus.
次要结局
- Association of exhaled biomarkers with participants' characteristics (age, gender, symptoms-severity, etc.)(Through the study completion, up to 3 months.)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Detection of COVID-19 Using Breath Analysis - Validation StudyCovid19NCT04602949Scentech Medical Technologies Ltd2,558
已完成
不适用
Early Detection of COVID-19 Using Breath Analysis - Feasibility StudyCovid19NCT04602871Scentech Medical Technologies Ltd54
招募中
不适用
Detection COVID-19 from exhaled air analysed with Aeonose™COVID-19NL-OMON27499eNose3,000
撤回
不适用
SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystemCOVID19NCT04497610Instituto Costarricense de Investigaciones Clínicas ICIC
已完成
不适用
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 StudyCovid19NCT04508556Owlstone Ltd40